-
1Academic Journal
Source: Мать и дитя в Кузбассе, Vol 25, Iss 4, Pp 4-11 (2024)
Subject Terms: женское бесплодие, факторы риска, медицинская помощь, Pediatrics, RJ1-570, Gynecology and obstetrics, RG1-991
File Description: electronic resource
-
2Academic Journal
Source: Мать и дитя в Кузбассе, Vol 25, Iss 3, Pp 26-32 (2024)
Subject Terms: мужское бесплодие, женское бесплодие, генетические нарушения, aufi, экстракорпоральное оплодотворение, интрацитоплазматическое введение спермы, Pediatrics, RJ1-570, Gynecology and obstetrics, RG1-991
File Description: electronic resource
-
3Academic Journal
Authors: Ражапова , Г.Ф., Олимова, К.Ж.
Source: Eurasian Journal of Medical and Natural Sciences; Vol. 5 No. 11 (2025): Eurasian Journal of Medical and Natural Sciences; 149-158 ; Евразийский журнал медицинских и естественных наук; Том 5 № 11 (2025): Евразийский журнал медицинских и естественных наук; 149-158 ; Yevrosiyo tibbiyot va tabiiy fanlar jurnali; Jild 5 Nomeri 11 (2025): Евразийский журнал медицинских и естественных наук; 149-158 ; 2181-287X
Subject Terms: Синд ром пустых фолликулов, женское бесплодие, фолликулярная жидкость, цинк, селен, оксидативный стресс, биомаркеры, Empty follicle syndrome, female infertility, follicular fluid, zinc, selenium, oxidative stress, biomarkers, Пуч фолликула синдроми, аёллар бепуштлиги, фолликуляр суюқлик, оксидатив стресс, биомаркер
File Description: application/pdf
Availability: https://in-academy.uz/index.php/EJMNS/article/view/65688
-
4Academic Journal
Authors: M. I. Shtaut, O. A. Solovova, N. V. Shilova, V. B. Chernykh, М. И. Штаут, О. А. Соловова, Н. В. Шилова, В. Б. Черных
Contributors: The work was carried out within the framework of the state assignment of the Ministry of Education and Science of Russia for the Research Centre for Medical Genetics., Работа выполнена в рамках государственного задания Минобрнауки России для ФГБНУ «МГНЦ».
Source: Medical Genetics; Том 24, № 9 (2025); 140-143 ; Медицинская генетика; Том 24, № 9 (2025); 140-143 ; 2073-7998
Subject Terms: женское бесплодие, X chromosome, chromosomal abnormalities, female infertility, хромосома Х, хромосомные аномалии
File Description: application/pdf
Relation: https://www.medgen-journal.ru/jour/article/view/3201/2061; Brambila-Tapia A.J., Rivera H., García-Castillo H., et al. 47,XXX/45,X/46,XX mosaicism in a patient with Turner phenotype and spontaneous pubertal development. Fertil Steril. 2009;92(5):1747. e5-7.; Gravholt C.H. Clinical practice in Turner syndrome. Nat Clin Pract Endocrinol Metab 2005;1:41–52.; Pal A.K., Ambulkar P.S., Sontakke B.R., et al. A study on chromosomal analysis of patients with primary amenorrhea. J Hum Reprod Sci 2019; 12(1):29–34.; Sybert V.P. Phenotypic effects of mosaicism for a 47,XXX cell line in Turner syndrome. J Med Genet 2002;39:217–220.; Liu C., Li Z., Li X., et al. Cytogenetic Analysis of a Patient with Turner Syndrome (45,X/47,XXX/48,XXXX/46,XX). Clin Lab. 2024;70(10).; Tarani L., Lampariello S., Raguso G., et al. Pregnancy in patients with Turner’s syndrome. Six new cases and review of literature. Gynecol Endocrinol 1998;12:83–7.
-
5Academic Journal
Authors: V. A. Stepanova, В. А. Степанова
Source: Vestnik Universiteta; № 12 (2024); 240-248 ; Вестник университета; № 12 (2024); 240-248 ; 2686-8415 ; 1816-4277
Subject Terms: супружеский копинг, female infertility of unclear etiology, intermarital relations, family communication system, marital satisfaction, marital coping, женское бесплодие неясной этиологии, межсупружеские отношения, коммуникационная система семьи, удовлетворенность браком
File Description: application/pdf
Relation: https://vestnik.guu.ru/jour/article/view/5754/3207; Малярская М.М. Социально-медицинские аспекты бесплодного брака (обзор литературы). Проблемы репродуктологии. 1996;1:20–22.; Тювина Н.А., Балабанова В.В., Николаевская А.О. Психосоматические механизмы идиопатического бесплодия: клинические наблюдения. Неврология, нейропсихиатрия, психосоматика. 2023;1(15):77–82. https://doi.org/10.14412/2074-2711-2023-1-77-82; Ицкович М.М., Полякова И.Г., Сыманюк Э.Э. Эффективность психокоррекционного воздействия методами имагинативной психотерапии при идиопатическом бесплодии. Экспериментальная психология. 2024;7(17):214–234. https://doi.org/10.17759/exppsy.2024170114; Голенков А.В., Мадянов И.В., Шмелева С.В., Петрова Г.Д., Камынина Н.Н., Логачев Н.В. Взаимосвязь индекса массы тела и психических расстройств у взрослого населения. Здравоохранение РФ. 2020;6(64):336–342. https://doi.org/10.46563/0044-197X-2020-64-6-336-342; Голенков А.В., Бонкало Т.И., Камынина Н.Н., Шмелева С.В. Осведомленность населения о депрессии и методах ее лечения. Здравоохранение РФ. 2021;5(65):425–431. http://dx.doi.org/10.47470/0044-197X-2021-65-5-425-431; Shin H., Lee J., Kim Sh., Jo M. Associations of Symptoms of Depression, Social Support, and Quality of Life Among Korean Women Who Experience Infertility. Journal of Obstetric, Gynecologic & Neonatal Nursing. 2021;6(50):e1–e12. https://doi.org/10.1016/j.jogn.2021.06.007; Mulhall J.P., Shindel A., Naughton C., Ohebshalom M., Nelson C. O-70: Sexual function, quality of life and their correlates in the female partner of infertile couples. Fertility and Sterility. 2006;3(86):530. https://doi.org/10.1016/j.fertnstert.2006.07.083; Шестакова О.В., Тетелютина Ф.К. Качество жизни и особенности психоэмоционального состояния в супружеской паре при бесплодном браке. Современные проблемы науки и образования. 2015;6.; Клейменова Л.А., Кононенко И.О. Идиопатическое бесплодие как психологическая проблема. Молодой ученый. 2019;27(265):149–153.; Гаврилова В.Е. Психологические предпосылки бесплодия у здоровых женщин, состоящих в браке. Вестник Южно-Уральского государственного университета. Серия: Психология. 2018;3(11):103–109. http://dx.doi.org/10.14529/psy180312; Ермошенко Б.Г., Крутова В.А. Роль психологических факторов при бесплодии (обзор литературы). Успехи современного естествознания. 2005;8:17–20.; Восканян Я.Ю., Васильева О.С. Психологические особенности женщин с бесплодием неясной этиологии. Северо-Кавказский психологический вестник. 2022;4(20). https://doi.org/10.21702/ncpb.2022.4.4; Восканян Я.Ю., Васильева О.С. Психологические аспекты женского бесплодия неясной этиологии: обзор зарубежных исследований. Мир науки. Педагогика и психология. 2024;1(12). https://doi.org/10.15862/39PSMN124; Василенко Т.Д., Блюм А.И. Бесплодие неясной этиологии как особая кризисная ситуация неопределенности в жизни женщины. Innova. 2017;1(6):17–20. https://doi.org/10.21626/innova/2017.1/03; Снегирева Т.В. «Добровольно бездетная» семья глазами семейного психолога. Культурно-историческая психология. 2010;3(6):99–109.; Бонкало Т.И. Социально-психологический патернализм школы и семьи: теория, методология, практика. Коломна; 2011. 349 с.; Бонкало Т.И., Маринова Т.Ю., Феоктистова С.В., Шмелева С.В. Диадические копинг-стратегии супругов как фактор латентных дисфункциональных отношений в семье: опыт эмпирического исследования в период пандемии. Социальная психология и общество. 2020;3(11):35–50. https://doi.org/10.17759/sps.2020110303; Прохоренко Ю.И. Репродуктивное насилие: постановка проблемы. Ученые записки ТОГУ. 2019;3(10):99–104.; Майерс Д.Н., Шилова Т.А. Формирование копинг-стратегий при решении конфликтных (стрессовых) ситуаций в семейных отношениях. Научный лидер. 2022;22(67):12–24.; Волков А.Е. Внутренняя картина беременности. В кн.: Перинатальная психология и медицина, психосоматические расстройства в акушерстве, гинекологии, педиатрии и терапии: материалы Всероссийской конференции, Иваново, 2011. Иваново; 2011. С. 117–120.; Федина Л.П. Межличностные конфликты, возникающие на фоне принятия решения о преодолении бесплодия методом ЭКО. В кн.: Психология в России и за рубежом: материалы Международной научной конференции, Санкт-Петербург, 20–23 октября 2011 г. СПб: Реноме; 2011. С. 63–65.; Приленский Ю.Ф. Бесплодные браки. СПб.: Питер; 2004. 188 с.; Bourey C., Murray S. Intimate partner violence among women with infertility. The Lancet Global Health. 2022;6(10):e778–e779. https://doi.org/10.1016/S2214-109X(22)00205-4; Куфтяк Е.В. Адаптация опросника «Супружеский копинг». Вестник Санкт-Петербургского университета. Серия 12. Социология. 2009;3:246–254.; https://vestnik.guu.ru/jour/article/view/5754
-
6Academic Journal
Source: Мать и дитя в Кузбассе, Vol 25, Iss 4, Pp 4-11 (2024)
Subject Terms: медицинская помощь, RG1-991, факторы риска, Gynecology and obstetrics, Pediatrics, RJ1-570, женское бесплодие
-
7Academic Journal
Source: Мать и дитя в Кузбассе, Vol 25, Iss 3, Pp 26-32 (2024)
-
8Academic Journal
Source: Mother and Baby in Kuzbass; № 4 (2024): декабрь; 4-11 ; Мать и Дитя в Кузбассе; № 4 (2024): декабрь; 4-11 ; 2542-0968 ; 1991-010X
Subject Terms: female infertility, risk factors, medical care, женское бесплодие, факторы риска, медицинская помощь
File Description: text/html; application/pdf
Relation: http://mednauki.ru/index.php/MD/article/view/1139/1968; http://mednauki.ru/index.php/MD/article/view/1139/1972; http://mednauki.ru/index.php/MD/article/view/1139
Availability: http://mednauki.ru/index.php/MD/article/view/1139
-
9Academic Journal
Source: Mother and Baby in Kuzbass; № 3 (2024): сентябрь; 26-32 ; Мать и Дитя в Кузбассе; № 3 (2024): сентябрь; 26-32 ; 2542-0968 ; 1991-010X
Subject Terms: male infertility, female infertility, genetic disorders, AUFI, in vitro fertilization, intracytoplasmic sperm injection, мужское бесплодие, женское бесплодие, генетические нарушения, экстракорпоральное оплодотворение, интрацитоплазматическое введение спермы
File Description: text/html; application/pdf
Relation: http://mednauki.ru/index.php/MD/article/view/1102/1907; http://mednauki.ru/index.php/MD/article/view/1102/1921; http://mednauki.ru/index.php/MD/article/view/1102
Availability: http://mednauki.ru/index.php/MD/article/view/1102
-
10Academic Journal
Authors: Timoshkova Y.L., Andrianov M.A., Makeev K.A., Kurmanbaev T.E., Makeev A.T.
Contributors: 1
Source: Marine Medicine; Vol 10, No 1 (2024); 105-111 ; Морская медицина; Vol 10, No 1 (2024); 105-111 ; 2587-7828 ; 2413-5747
Subject Terms: marine medicine, female infertility, incidence, causes, female militaries, морская медицина, женское бесплодие, частота, причины, военнослужащие женского пола
File Description: application/pdf
Relation: https://seamed.bmoc-spb.ru/jour/article/view/613/616; https://seamed.bmoc-spb.ru/jour/article/downloadSuppFile/613/176; https://seamed.bmoc-spb.ru/jour/article/downloadSuppFile/613/177; https://seamed.bmoc-spb.ru/jour/article/downloadSuppFile/613/353; ODDZCB
-
11Academic Journal
Authors: I. A. Mazerkina, I. G. Davydov, O. S. Alyautdina, И. А. Мазеркина, И. Г. Давыдов, О. С. Аляутдина
Contributors: The study reported in this publication was carried out as part of publicly funded research project No. 056-00026-24-00 and was supported by the Scientific Centre for Expert Evaluation of Medicinal Products (R&D reporting No. 124022300127-0)., Работа выполнена в рамках государственного задания ФГБУ «НЦЭСМП» Минздрава России № 056-00026-24-00 на проведение прикладных научных исследований (номер государственного учета НИР 124022300127-0).
Source: Safety and Risk of Pharmacotherapy; Том 12, № 2 (2024); 214-229 ; Безопасность и риск фармакотерапии; Том 12, № 2 (2024); 214-229 ; 2619-1164 ; 2312-7821 ; 10.30895/2312-7821-2024-12-2
Subject Terms: женщины, combined oral contraceptives, oestrogens, progestogens, female infertility, hyperandrogenism, hirsutism, metabolic syndrome, safety of combined oral contraceptives, women, комбинированные оральные контрацептивы, эстрогены, прогестагены, женское бесплодие, гиперандрогения, гирсутизм, метаболический синдром, безопасность комбинированных оральных контрацептивов
File Description: application/pdf
Relation: https://www.risksafety.ru/jour/article/view/426/1156; https://www.risksafety.ru/jour/article/downloadSuppFile/426/518; Адамян ЛВ, Андреева ЕН, Абсатарова ЮС, Григорян ОР, Дедов ИИ, Мельниченко ГА и др. Клинические рекомендации «Синдром поликистозных яичников». Проблемы эндокринологии. 2022;68(2):112–27. https://doi.org/10.14341/probl12874; Teede HJ, Tay CT, Laven JJE, Dokras A, Moran LJ, Piltonen TT, et al. Recommendations from the 2023 international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Eur J Endocrinol. 2023;189(2):G43–G64. https://doi.org/10.1093/ejendo/lvad096; Goodman NF, Cobin RH, Futterweit W, Glueck JS, Legro RS, Carmina E, et al. American Association of Clinical Endocrinologists, American College of Endocrinology, and Androgen Excess and PCOS Society Disease State clinical review: guide to the best practices in the evaluation and treatment of polycystic ovary syndrome — Part 1. Endocr Pract. 2015;21(11):1291–300. https://doi.org/10.4158/EP15748.DSC; Goodman NF, Cobin RH, Futterweit W, Glueck JS, Legro RS, Carmina E, et al. American Association of Clinical Endocrinologists, American College of Endocrinology, and Androgen Excess and PCOS Society Disease State clinical review: guide to the best practices in the evaluation and treatment of polycystic ovary syndrome — Part 2. Endocr Pract. 2015;21(12):1415–26. https://doi.org/10.4158/EP15748.DSCPT2; Rotterdam ESHRE/ASRM-Sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod. 2004;19(1):41–7. https://doi.org/10.1093/humrep/deh098; Mumusoglu S, Yildiz BO. Polycystic ovary syndrome phenotypes and prevalence: differential impact of diagnostic criteria and clinical versus unselected population. Curr Opin Endocr Metab Res. 2020;12:66–71. https://doi.org/10.1016/j.coemr.2020.03.004; Bozdag G, Mumusoglu S, Zengin D, Karabulut E, Yildiz BO. The prevalence and phenotypic features of polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod. 2016;31(12):2841–55. https://doi.org/10.1093/humrep/dew218; Emanuel RHK, Roberts J, Docherty PD, Lunt H, Campbell RE, Möller K. A review of the hormones involved in the endocrine dysfunctions of polycystic ovary syndrome and their interactions. Front Endocrinol (Lausanne). 2022;13:1017468. https://doi.org/10.3389/fendo.2022.1017468; Moghetti P, Tosi F, Bonin C, Di Sarra D, Fiers T, Kaufman JM, et al. Divergences in insulin resistance between the different phenotypes of the polycystic ovary syndrome. J Clin Endocrinol Metab. 2013;98(4):E628–37. https://doi.org/10.1210/jc.2012-3908; Bremer AA, Miller WL. The serine phosphorylation hypothesis of polycystic ovary syndrome: a unifying mechanism for hyperandrogenemia and insulin resistance. Fertil Steril. 2008;89(5):1039–48. https://doi.org/10.1016/j.fertnstert.2008.02.091; Qiao J, Feng HL. Extra- and intra-ovarian factors in polycystic ovary syndrome: impact on oocyte maturation and embryo developmental competence. Hum Reprod Update. 2011;17(1):17–33. https://doi.org/10.1093/humupd/dmq032; Melo AS, Ferriani RA, Navarro PA. Treatment of infertility in women with polycystic ovary syndrome: approach to clinical practice. Clinics (São Paulo). 2015;70(11):765–9. https://doi.org/10.6061/clinics/2015(11)09; Krentowska A, Kowalska I. Metabolic syndrome and its components in different phenotypes of polycystic ovary syndrome. Diabetes Metab Res Rev. 2022;38(1):e3464. https://doi.org/10.1002/dmrr.3464; Jacewicz-Święcka M, Kowalska I. Changes in metabolic profile in the women with a history of PCOS-A long-term follow-up study. J Clin Med. 2020;9(10):3367. https://doi.org/10.3390/jcm9103367; Wang Y, Ni Z, Li K. The prevalence of anxiety and depression of different severity in women with polycystic ovary syndrome: a meta-analysis. Gynecol Endocrinol. 2021;37(12):1072–8. https://doi.org/10.1080/09513590.2021.1942452; Brutocao C, Zaiem F, Alsawas M, Morrow AS, Murad MH, Javed A. Psychiatric disorders in women with polycystic ovary syndrome: a systematic review and meta-analysis. Endocrine. 2018;62(2):318–25. https://doi.org/10.1007/s12020-018-1692-3; Bellver J, Rodríguez-Tabernero L, Robles A, Muñoz E, Martínez F, Landeras J, et al. Polycystic ovary syndrome throughout a woman’s life. J Assist Reprod Genet. 2018;35(1):25–39. https://doi.org/10.1007/s10815-017-1047-7; Meczekalski B, Pérez-Roncero GR, López-Baena MT, Chedraui P, Pérez-López FR. The polycystic ovary syndrome and gynecological cancer risk. Gynecol Endocrinol. 2020;36(4):289–93. https://doi.org/10.1080/09513590.2020.1730794; Yin W, Falconer H, Yin L, Xu L, Ye W. Association between polycystic ovary syndrome and cancer risk. JAMA Oncol. 2019;5(1):106–7. https://doi.org/10.1001/jamaoncol.2018.5188; Сухих ГТ, Прилепская ВН, ред. Национальные медицинские критерии приемлемости методов контрацепции. М.; 2023. EDN: EFKVBW; Morimont L, Haguet H, Dogné JM, Gaspard U, Douxfils J. Combined oral contraceptives and venous thromboembolism: review and perspective to mitigate the risk. Front Endocrinol (Lausanne). 2021;12:769187. https://doi.org/10.3389/fendo.2021.769187; Sitruk-Ware R, Nath A. Characteristics and metabolic effects of estrogen and progestins contained in oral contraceptive pills. Best Pract Res Clin Endocrinol Metab. 2013;27(1):13–24. https://doi.org/10.1016/j.beem.2012.09.004; Schindler AE, Campagnoli C, Druckmann R, Huber J, Pasqualini JR, Schweppe KW, Thijssen JH. Classification and pharmacology of progestins. Maturitas. 2003;46 Suppl 1:S7–S16. https://doi.org/10.1016/j.maturitas.2003.09.014; Seidman L, Kroll R, Howard B, Ricciotti N, Hsieh J, Weiss H. Ovulatory effects of three oral contraceptive regimens: a randomized, open-label, descriptive trial. Contraception. 2015;91(6):495–502. https://doi.org/10.1016/j.contraception.2015.03.001; Rivera R, Yacobson I, Grimes D. The mechanism of action of hormonal contraceptives and intrauterine contraceptive devices. Am J Obstet Gynecol. 1999;181(5 Pt 1):1263–9. https://doi.org/10.1016/s0002-9378(99)70120-1; Fraser IS, Römer T, Parke S, Zeun S, Mellinger U, Machlitt A, Jensen JT. Effective treatment of heavy and/ or prolonged menstrual bleeding with an oral contraceptive containing estradiol valerate and dienogest: a randomized, double-blind Phase III trial. Hum Reprod. 2011;26(10):2698–708. https://doi.org/10.1093/humrep/der224; Klipping C, Duijkers I, Trummer D, Marr J. Suppression of ovarian activity with a drospirenone-containing oral contraceptive in a 24/4 regimen. Contraception. 2008;78(1):16–25. https://doi.org/10.1016/j.contraception.2008.02.019; Ferriman D, Gallwey Jd. Clinical assessment of body hair growth in women. J Clin Endocrinol Metab. 1961;21:1440–7. https://doi.org/10.1210/jcem-21-11-1440; Bienenfeld A, Azarchi S, Lo Sicco K, Marchbein S, Shapiro J, Nagler AR. Androgens in women: androgen-mediated skin disease and patient evaluation. J Am Acad Dermatol. 2019;80(6):1497–506. https://doi.org/10.1016/j.jaad.2018.08.062; Azziz R, Carmina E, Chen Z, Dunaif A, Laven JS, Legro RS, et al. Polycystic ovary syndrome. Nat Rev Dis Primers. 2016;2:16057. https://doi.org/10.1038/nrdp.2016.57; Pasquali R, Gambineri A. Therapy in endocrine disease: treatment of hirsutism in the polycystic ovary syndrome. Eur J Endocrinol. 2014;170(2):R75–90. https://doi.org/10.1530/EJE-13-0585; Ceruti JM, Leirós GJ, Balañá ME. Androgens and androgen receptor action in skin and hair follicles. Mol Cell Endocrinol. 2018;465:122–33. https://doi.org/10.1016/j.mce.2017.09.009; Spritzer PM, Marchesan LB, Santos BR, Fighera TM. Hirsutism, Normal androgens and diagnosis of PCOS. Diagnostics (Basel). 2022;12(8):1922. https://doi.org/10.3390/diagnostics12081922; Lowenstein EJ. Diagnosis and management of the dermatologic manifestations of the polycystic ovary syndrome. Dermatol Ther. 2006;19(4):210–23. https://doi.org/10.1111/j.1529-8019.2006.00077.x; Legro RS, Arslanian SA, Ehrmann DA, Hoeger KM, Murad MH, Pasquali R, et al. Diagnosis and treatment of polycystic ovary syndrome: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2013;98(12):4565–92. https://doi.org/10.1210/jc.2013-2350; Borzyszkowska D, Niedzielska M, Kozłowski M, Brodowska A, Przepiera A, Malczyk-Matysiak K, et al. Evaluation of hormonal factors in acne vulgaris and the course of acne vulgaris treatment with contraceptive-based therapies in young adult women. Cells. 2022;11(24):4078. https://doi.org/10.3390/cells11244078; Ozdemir S, Ozdemir M, Görkemli H, Kiyici A, Bodur S. Specific dermatologic features of the polycystic ovary syndrome and its association with biochemical markers of the metabolic syndrome and hyperandrogenism. Acta Obstet Gynecol Scand. 2010;89(2):199–204. https://doi.org/10.3109/00016340903353284; Feng JG, Guo Y, Ma LA, Xing J, Sun RF, Zhu W. Prevalence of dermatologic manifestations and metabolic biomarkers in women with polycystic ovary syndrome in north China. J Cosmet Dermatol. 2018;17(3):511–7. https://doi.org/10.1111/jocd.12387; Schmidt TH, Khanijow K, Cedars MI, Huddleston H, Pasch L, Wang ET, et al. Cutaneous findings and systemic associations in women with polycystic ovary syndrome. JAMA Dermatol. 2016;152(4):391–8. https://doi.org/10.1001/jamadermatol.2015.4498; Hoeger KM, Dokras A, Piltonen T. Update on PCOS: consequences, challenges, and guiding treatment. J Clin Endocrinol Metab. 2021;106(3):e1071–83. https://doi.org/10.1210/clinem/dgaa839; Amiri M, Kabir A, Nahidi F, Shekofteh M, Ramezani Tehrani F. Effects of combined oral contraceptives on the clinical and biochemical parameters of hyperandrogenism in patients with polycystic ovary syndrome: a systematic review and meta-analysis. Eur J Contracept Reprod Health Care. 2018;23(1):64–77. https://doi.org/10.1080/13625187.2018.1435779; Morgante G, Cappelli V, Troìa L, De Leo V. Evaluation of different antiandrogenic progestins on clinical and biochemical variables in polycystic ovary syndrome. Eur J Contracept Reprod Health Care. 2020;25(3):176–81. https://doi.org/10.1080/13625187.2020.1736546; De Leo V, Morgante G, Piomboni P, Musacchio MC, Petraglia F, Cianci A. Evaluation of effects of an oral contraceptive containing ethinylestradiol combined with drospirenone on adrenal steroidogenesis in hyperandrogenic women with polycystic ovary syndrome. Fertil Steril. 2007;88(1):113–7. https://doi.org/10.1016/j.fertnstert.2006.11.137; Barrionuevo P, Nabhan M, Altayar O, Wang Z, Erwin PJ, Asi N, et al. Treatment options for hirsutism: a systematic review and network meta-analysis. J Clin Endocrinol Metab. 2018;103(4):1258–64. https://doi.org/10.1210/jc.2017-02052; Bhattacharya SM, Jha A. Comparative study of the therapeutic effects of oral contraceptive pills containing desogestrel, cyproterone acetate, and drospirenone in patients with polycystic ovary syndrome. Fertil Steril. 2012;98(4):1053–9. https://doi.org/10.1016/j.fertnstert.2012.06.035; Tang Z, Guan J, Mao JH, Han L, Zhang JJ, Chen R, Jiao Z. Quantitative risk-benefit profiles of oral contraceptives, insulin sensitizers and antiandrogens for women with polycystic ovary syndrome: a model-based meta-analysis. Eur J Pharm Sci. 2023;190:106577. https://doi.org/10.1016/j.ejps.2023.106577; Dorgham N, Sharobim A, Haggag H, El-Kalioby M, Dorgham D. Adding combined oral contraceptives or metformin to laser treatment in polycystic ovarian syndrome hirsute patients. J Drugs Dermatol. 2021;20(3):302–6. https://doi.org/10.36849/JDD.5652; Shobeiri F, Jenabi E. The association between polycystic ovary syndrome and breast cancer: a meta-analysis. Obstet Gynecol Sci. 2016;59(5):367–72. https://doi.org/10.5468/ogs.2016.59.5.367; Harris HR, Terry KL. Polycystic ovary syndrome and risk of endometrial, ovarian, and breast cancer: a systematic review. Fertil Res Pract. 2016;2:14. https://doi.org/10.1186/s40738-016-0029-2; Ding DC, Chen W, Wang JH, Lin SZ. Association between polycystic ovarian syndrome and endometrial, ovarian, and breast cancer: a population-based cohort study in Taiwan. Medicine (Baltimore). 2018;97(39):e12608. https://doi.org/10.1097/MD.0000000000012608; Li Z, Wang YH, Wang LL, Hu DT, Teng Y, Zhang TY, et al. Polycystic ovary syndrome and the risk of endometrial, ovarian and breast cancer: an updated meta-analysis. Scott Med J. 2022;67(3):109–20. https://doi.org/10.1177/00369330221107099; Collaborative Group on Hormonal Factors in Breast Cancer. Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53297 women with breast cancer and 100239 women without breast cancer from 54 epidemiological studies. Lancet. 1996;347(9017):1713–27. https://doi.org/10.1016/s0140-6736(96)90806-5; Mørch LS, Hannaford PC, Lidegaard Ø. Contemporary hormonal contraception and the risk of breast cancer. N Engl J Med. 2018;378(13):1265–6. https://doi.org/10.1056/NEJMc1800054; Fitzpatrick D, Pirie K, Reeves G, Green J, Beral V. Combined and progestagen-only hormonal contraceptives and breast cancer risk: a UK nested case–control study and meta-analysis. PLOS Medicine. 2023;20(3):e1004188. https://doi.org/10.1371/journal.pmed.1004188; Iversen L, Sivasubramaniam S, Lee AJ, Fielding S, Hannaford PC. Lifetime cancer risk and combined oral contraceptives: the Royal College of General Practitioners’ oral contraception study. Am J Obstet Gynecol. 2017;216(6):580.e1–580.e9. https://doi.org/10.1016/j.ajog.2017.02.002; Gottschau M, Kjaer SK, Jensen A, Munk C, Mellemkjaer L. Risk of cancer among women with polycystic ovary syndrome: a Danish cohort study. Gynecol Oncol. 2015;136(1):99–103. https://doi.org/10.1016/j.ygyno.2014.11.012; Dumesic DA, Lobo RA. Cancer risk and PCOS. Steroids. 2013;78(8):782–5. https://doi.org/10.1016/j.steroids.2013.04.004; Indhavivadhana S, Rattanachaiyanont M, Wongwananuruk T, Techatraisak K, Rayasawath N, Dangrat C. Endometrial neoplasia in reproductive-aged Thai women with polycystic ovary syndrome. Int J Gynaecol Obstet. 2018;142(2):170–5. https://doi.org/10.1002/ijgo.12522; Fearnley EJ, Marquart L, Spurdle AB, Weinstein P, Webb PM; Australian Ovarian Cancer Study Group and Australian National Endometrial Cancer Study Group. Polycystic ovary syndrome increases the risk of endometrial cancer in women aged less than 50 years: an Australian case-control study. Cancer Causes Control. 2010;21(12):2303–8. https://doi.org/10.1007/s10552-010-9658-7; Cooney LG, Dokras A. Beyond fertility: polycystic ovary syndrome and long-term health. Fertil Steril. 2018;110(5):794–809. https://doi.org/10.1016/j.fertnstert.2018.08.021; Savaris RF, Groll JM, Young SL, DeMayo FJ, Jeong JW, Hamilton AE, et al. Progesterone resistance in PCOS endometrium: a microarray analysis in clomiphene citrate-treated and artificial menstrual cycles. J Clin Endocrinol Metab. 2011;96(6):1737–46. https://doi.org/10.1210/jc.2010-2600; Li X, Feng Y, Lin JF, Billig H, Shao R. Endometrial progesterone resistance and PCOS. J Biomed Sci. 2014;21(1):2. https://doi.org/10.1186/1423-0127-21-2; Onstad MA, Schmandt RE, Lu KH. Addressing the role of obesity in endometrial cancer risk, prevention, and treatment. J Clin Oncol. 2016;34(35):4225–30. https://doi.org/10.1200/JCO.2016.69.4638; Pérez-Martín AR, Castro-Eguiluz D, Cetina-Pérez L, Velasco-Torres Y, Bahena-González A, Montes-Servín E, et al. Impact of metabolic syndrome on the risk of endometrial cancer and the role of lifestyle in prevention. Bosn J Basic Med Sci. 2022;22(4):499–510. https://doi.org/10.17305/bjbms.2021.6963; Michels KA, Pfeiffer RM, Brinton LA, Trabert B. Modification of the associations between duration of oral contraceptive use and ovarian, endometrial, breast, and colorectal cancers. JAMA Oncol. 2018;4(4):516–21. https://doi.org/10.1001/jamaoncol.2017.4942; Burchardt NA, Shafrir AL, Kaaks R, Tworoger SS, Fortner RT. Oral contraceptive use by formulation and endometrial cancer risk among women born in 1947– 1964: The Nurses’ Health Study II, a prospective cohort study. Eur J Epidemiol. 2021;36(8):827–39. https://doi.org/10.1007/s10654-020-00705-5; Cooney LG, Lee I, Sammel MD, Dokras A. High prevalence of moderate and severe depressive and anxiety symptoms in polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod. 2017;32(5):1075–91. https://doi.org/10.1093/humrep/dex044; Довженко ТВ, Ильина НА, Гродницкая ЕА. Проблема психических нарушений при синдроме поликистозных яичников. Социальная и клиническая психиатрия. 2015;25(2):94–100. EDN: UZQCVP; Edwards AC, Lönn SL, Crump C, Mościcki EK, Sundquist J, Kendler KS, Sundquist K. Oral contraceptive use and risk of suicidal behavior among young women. Psychol Med. 2022;52(9):1710–7. https://doi.org/10.1017/S0033291720003475; Jung SJ, Cho SMJ, Kim HC. Association of oral contraceptive use with suicidal behavior among representative Korean population: results from Korea National Health and Nutrition Examination Survey (2007–2016). J Affect Disord. 2019;243:8–15. https://doi.org/10.1016/j.jad.2018.09.004; Yang Q, Lagerberg T, Sjölander A, Bertone-Johnson ER, Fang F, Ye W, et al. Use of hormonal contraceptives and antidepressants and risks of suicidal behavior and accidents among women with premenstrual disorders: a nationwide cohort study. BMC Med. 2022;20(1):482. https://doi.org/10.1186/s12916-022-02671-z; Dokras A, Sarwer DB, Allison KC, Milman L, Kris-Etherton PM, Kunselman AR, et al. Weight loss and lowering androgens predict improvements in health-related quality of life in women with PCOS. J Clin Endocrinol Metab. 2016;101(8):2966–74. https://doi.org/10.1210/jc.2016-1896; Cinar N, Harmanci A, Demir B, Yildiz BO. Effect of an oral contraceptive on emotional distress, anxiety and depression of women with polycystic ovary syndrome: a prospective study. Hum Reprod. 2012;27(6):1840–5. https://doi.org/10.1093/humrep/des113; Amisi CA. Markers of insulin resistance in polycystic ovary syndrome women: an update. World J Diabetes. 2022;13(3):129–49. https://doi.org/10.4239/wjd.v13.i3.129; Barber TM. Why are women with polycystic ovary syndrome obese? British Medical Bulletin. 2022;143(1):4–15. https://doi.org/10.1093/bmb/ldac007; Guo F, Gong Z, Fernando T, Zhang L, Zhu X, Shi Y. The lipid profiles in different characteristics of women with PCOS and the interaction between dyslipidemia and metabolic disorder states: a retrospective study in Chinese population. Front Endocrinol (Lausanne). 2022;13:892125. https://doi.org/10.3389/fendo.2022.892125; Kazemi M, Pierson RA, Lujan ME, Chilibeck PD, McBreairty LE, Gordon JJ, et al. Comprehensive evaluation of type 2 diabetes and cardiovascular disease risk profiles in reproductive-age women with polycystic ovary syndrome: a large Canadian cohort. J Obstet Gynaecol Can. 2019;41(10):1453–60. https://doi.org/10.1016/j.jogc.2018.11.026; Болотова ЕВ, Дудникова АВ, Крутова ВА, Просолупова НС. Частота и структура метаболических нарушений у женщин с ожирением в сочетании с синдромом поликистозных яичников. Ожирение и метаболизм. 2021;18(3):254–62. https://doi.org/10.14341/omet12374; Kakoly NS, Khomami MB, Joham AE, Cooray SD, Misso ML, Norman RJ, et al. Ethnicity, obesity and the prevalence of impaired glucose tolerance and type 2 diabetes in PCOS: a systematic review and meta-regression. Hum Reprod Update. 2018;24(4):455–67. https://doi.org/10.1093/humupd/dmy007; Sanchez-Garrido MA, Tena-Sempere M. Metabolic dysfunction in polycystic ovary syndrome: pathogenic role of androgen excess and potential therapeutic strategies. Mol Metab. 2020;35:100937. https://doi.org/10.1016/j.molmet.2020.01.001; Li L, Feng Q, Ye M, He Y, Yao A, Shi K. Metabolic effect of obesity on polycystic ovary syndrome in adolescents: a meta-analysis. J Obstet Gynaecol. 2017;37(8):1036–47. https://doi.org/10.1080/01443615.2017.1318840; Behboudi-Gandevani S, Ramezani Tehrani F, Rostami Dovom M, Farahmand M, Bahri Khomami M, Noroozzadeh M, et al. Insulin resistance in obesity and polycystic ovary syndrome: systematic review and meta-analysis of observational studies. Gynecol Endocrinol. 2016;32(5):343–53. https://doi.org/10.3109/09513590.2015.1117069; Ollila MM, West S, Keinänen-Kiukaanniemi S, Jokelainen J, Auvinen J, Puukka K, et al. Overweight and obese but not normal weight women with PCOS are at increased risk of type 2 diabetes mellitus—a prospective, population-based cohort study. Hum Reprod. 2017;32(2):423–31. https://doi.org/10.1093/humrep/dew329; Forslund M, Landin-Wilhelmsen K, Trimpou P, Schmidt J, Brännström M, Dahlgren E. Type 2 diabetes mellitus in women with polycystic ovary syndrome during a 24-year period: importance of obesity and abdominal fat distribution. Hum Reprod Open. 2020;(1):hoz042. https://doi.org/10.1093/hropen/hoz042; Kumarendran B, O’Reilly MW, Subramanian A, Šumilo D, Toulis K, Gokhale KM, et al. Polycystic ovary syndrome, combined oral contraceptives, and the risk of dysglycemia: a population-based cohort study with a nested pharmacoepidemiological case-control study. Diabetes Care. 2021;44(12):2758–66. https://doi.org/10.2337/dc21-0437; Wu L, Liu Y, Huang X, Lin K, Liu Y, Li Z, et al. Oral contraceptives (OCs) in combination with metformin versus OCs alone on metabolism in nonobese polycystic ovary syndrome: a meta-analysis and systematic review of randomized controlled trials. Clin Endocrinol (Oxf). 2023;99(1):3–16. https://doi.org/10.1111/cen.14895; Gallo MF, Lopez LM, Grimes DA, Carayon F, Schulz KF, Helmerhorst FM. Combination contraceptives: effects on weight. Cochrane Database Syst Rev. 2014;2014(1):CD003987. https://doi.org/10.1002/14651858.CD003987.pub5; Hirschberg AL, Byström B, Carlström K, von Schoultz B. Reduced serum cholecystokinin and increase in body fat during oral contraception. Contraception. 1996;53(2):109–13. https://doi.org/10.1016/0010-7824(95)00265-0; Arusoglu G, Koksal G, Cinar N, Tapan S, Aksoy DY, Yildiz BO. Basal and meal-stimulated ghrelin, PYY, CCK levels and satiety in lean women with polycystic ovary syndrome: effect of low-dose oral contraceptive. J Clin Endocrinol Metab. 2013;98(11):4475–82. https://doi.org/10.1210/jc.2013-1526; Naessén S, Carlström K, Byström B, Pierre Y, Hirschberg AL. Effects of an antiandrogenic oral contraceptive on appetite and eating behavior in bulimic women. Psychoneuroendocrinology. 2007;32(5):548–54. https://doi.org/10.1016/j.psyneuen.2007.03.008; Lindh I, Ellström AA, Milsom I. The long-term influence of combined oral contraceptives on body weight. Hum Reprod. 2011;26(7):1917–24. https://doi.org/10.1093/humrep/der094; Aydin K, Cinar N, Aksoy DY, Bozdag G, Yildiz BO. Body composition in lean women with polycystic ovary syndrome: effect of ethinyl estradiol and drospirenone combination. Contraception. 2013;87(3):358–62. https://doi.org/10.1016/j.contraception.2012.07.005; Berenson AB, Rahman M. Changes in weight, total fat, percent body fat, and central-to-peripheral fat ratio associated with injectable and oral contraceptive use. Am J Obstet Gynecol. 2009;200(3):329.e1–8. https://doi.org/10.1016/j.ajog.2008.12.052; Pasquali R, Gambineri A, Anconetani B, Vicennati V, Colitta D, Caramelli E, et al. The natural history of the metabolic syndrome in young women with the polycystic ovary syndrome and the effect of long-term oestrogen-progestagen treatment. Clin Endocrinol (Oxf). 1999;50(4):517–27. https://doi.org/10.1046/j.1365-2265.1999.00701.x; Cooney LG, Dokras A. Cardiometabolic risk in polycystic ovary syndrome: current guidelines. Endocrinol Metab Clin North Am. 2021;50(1):83–95. https://doi.org/10.1016/j.ecl.2020.11.001; Беглова АЮ, Елгина СИ. Метаболические и сердечно-сосудистые риски у женщин репродуктивного возраста с синдромом поликистозных яичников. Мать и дитя в Кузбассе. 2018;(4):44–9. EDN: YRNDGH; Amiri M, Ramezani Tehrani F, Behboudi-Gandevani S, Bidhendi-Yarandi R, Carmina E. Risk of hypertension in women with polycystic ovary syndrome: a systematic review, meta-analysis and meta-regression. Reprod Biol Endocrinol. 2020;18(1):23. https://doi.org/10.1186/s12958-020-00576-1; Daan NM, Louwers YV, Koster MP, Eijkemans MJ, de Rijke YB, Lentjes EW, et al. Cardiovascular and metabolic profiles amongst different polycystic ovary syndrome phenotypes: who is really at risk? Fertil Steril. 2014;102(5):1444–51.e3. https://doi.org/10.1016/j.fertnstert.2014.08.001; de Medeiros SF. Risks, benefits size and clinical implications of combined oral contraceptive use in women with polycystic ovary syndrome. Reprod Biol Endocrinol. 2017;15(1):93. https://doi.org/10.1186/s12958-017-0313-y; Yildizhan R, Gokce AI, Yildizhan B, Cim N. Comparison of the effects of chlormadinone acetate versus drospirenone containing oral contraceptives on metabolic and hormonal parameters in women with PCOS for a period of two-year follow-up. Gynecol Endocrinol. 2015;31(5):396–400. https://doi.org/10.3109/09513590.2015.1006187; Vieira CS, Martins WP, Fernandes JB, Soares GM, dos Reis RM, de Sá MF, Ferriani RA. The effects of 2 mg chormadinone acetate/30 mcg ethinylestradiol, alone or combined with spironolactone, on cardiovascular risk markers in women with polycystic ovary syndrome. Contraception. 2012;86:268–75. https://doi.org/10.1016/j.contraception.2011.12.011; Wild RA, Rizzo M, Clifton S, Carmina E. Lipid levels in polycystic ovary syndrome: systematic review and meta-analysis. Fertil Steril. 2011;95:1073–9.e1-11. https://doi.org/10.1016/j.fertnstert.2010.12.027; Pinola P, Puukka K, Piltonen TT, Puurunen J, Vanky E, Sundstrom-Poromaa I, et al. Normo- and hyperandrogenic women with polycystic ovary syndrome exhibit an adverse metabolic profile through life. Fertil Steril. 2017;107:788–95.e2. https://doi.org/10.1016/j.fertnstert.2016.12.017; Lorenz MW, Markus HS, Bots ML, Rosvall M, Sitzer M. Prediction of clinical cardiovascular events with carotid intima-media thickness: a systematic review and meta-analysis. Circulation. 2007;115(4):459–67. https://doi.org/10.1161/circulationaha.106.628875; Meyer ML, Malek AM, Wild RA, Korytkowski MT, Talbott EO. Carotid artery intima-media thickness in polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod Update. 2012;18(2):112–26. https://doi.org/10.1093/humupd/dmr046; Meun C, Franco OH, Dhana K, Jaspers L, Muka T, Louwers Y, et al. High androgens in postmenopausal women and the risk for atherosclerosis and cardiovascular disease: the Rotterdam Study. J Clin Endocrinol Metab. 2018;103:1622–30. https://doi.org/10.1210/jc.2017-02421; Guan C, Zahid S, Minhas AS, Ouyang P, Vaught A, Baker VL, Michos ED. Polycystic ovary syndrome: a “risk-enhancing” factor for cardiovascular disease. Fertil Steril. 2022;117(5):924–35. https://doi.org/10.1016/j.fertnstert.2022.03.009; Carmina E, Campagna AM, Lobo RA. A 20-year follow-up of young women with polycystic ovary syndrome. Obstet Gynecol. 2012;119(2 Pt 1):263–9. https://doi.org/10.1097/AOG.0b013e31823f7135; Ramezani Tehrani F, Amiri M, Behboudi-Gandevani S, Bidhendi-Yarandi R, Carmina E. Cardiovascular events among reproductive and menopausal age women with polycystic ovary syndrome: a systematic review and meta-analysis. Gynecol Endocrinol. 2020;36(1):12–23. https://doi.org/10.1080/09513590.2019.1650337; Schmidt J, Landin-Wilhelmsen K, Brännström M, Dahlgren E. Cardiovascular disease and risk factors in PCOS women of postmenopausal age: a 21-year controlled follow-up study. J Clin Endocrinol Metab. 2011;96(12):3794–803. https://doi.org/10.1210/jc.2011-1677; Bajuk Studen K, Pfeifer M. Cardiometabolic risk in polycystic ovary syndrome. Endocr Connect. 2018;7(7):R238–R251. https://doi.org/10.1530/EC-18-0129; Dragoman M, Curtis KM, Gaffield ME. Combined hormonal contraceptive use among women with known dyslipidemias: a systematic review of critical safety outcomes. Contraception. 2016;94(3):280–7. https://doi.org/10.1016/j.contraception.2015.08.002; Gariani K, Hugon-Rodin J, Philippe J, Righini M, Blondon M. Association between polycystic ovary syndrome and venous thromboembolism: a systematic review and meta-analysis. Thromb Res. 2020;185:102–8. https://doi.org/10.1016/j.thromres.2019.11.019; Lidegaard Ø, Nielsen LH, Skovlund CW, Skjeldestad FE, Løkkegaard E. Risk of venous thromboembolism from use of oral contraceptives containing different progestogens and oestrogen doses: Danish cohort study, 2001-9. BMJ. 2011;343:d6423. https://doi.org/10.1136/bmj.d6423; Карева ЕН. Тромбозы и гестагены. Доктор.Ру. 2019;(7):57–64. https://doi.org/10.31550/1727-2378-2019-162-7-57-64; Stocco B, Fumagalli HF, Franceschini SA, Martinez EZ, Marzocchi-Machado CM, de Sá MFS, Toloi MRT. Comparative study of the effects of combined oral contraceptives in hemostatic variables: an observational preliminary study. Medicine (Baltimore). 2015;94(4):e385. https://doi.org/10.1097/MD.0000000000000385; Bird ST, Hartzema AG, Brophy JM, Etminan M, Delaney JA. Risk of venous thromboembolism in women with polycystic ovary syndrome: a population-based matched cohort analysis. CMAJ. 2013;185(2):E115–20. https://doi.org/10.1503/cmaj.120677; Okoroh EM, Hooper WC, Atrash HK, Yusuf HR, Boulet SL. Is polycystic ovary syndrome another risk factor for venous thromboembolism? United States, 2003– 2008. Am J Obstet Gynecol. 2012;207(5):377.e1–8. https://doi.org/10.1016/j.ajog.2012.08.007; Girum T, Wasie A. Return of fertility after discontinuation of contraception: a systematic review and meta-analysis. Contracept Reprod Med. 2018;3:9. https://doi.org/10.1186/s40834-018-0064-y; Landersoe SK, Petersen KB, Vassard D, Larsen EC, Nielsen HS, Pinborg A, et al. Concerns on future fertility among users and past-users of combined oral contraceptives: a questionnaire survey. Eur J Contracept Reprod Health Care. 2019;24(5):347–55. https://doi.org/10.1080/13625187.2019.1639659; Yland JJ, Bresnick KA, Hatch EE, Wesselink AK, Mikkelsen EM, Rothman KJ, et al. Pregravid contraceptive use and fecundability: prospective cohort study. BMJ. 2020;371:m3966. https://doi.org/10.1136/bmj.m3966; Siegel DR, Fresia J, Fought A, Sheeder J, Hampanda K, Appiah L. The effect of hormonal contraception use on ovarian reserve markers and the uptake of assisted reproductive technology in individuals seeking an infertility evaluation. Cureus. 2023;15(6):e40927. https://doi.org/10.7759/cureus.40927; Song SY, Yang JB, Song MS, Oh HY, Lee GW, Lee M, et al. Effect of pretreatment with combined oral contraceptives on outcomes of assisted reproductive technology for women with polycystic ovary syndrome: a meta-analysis. Arch Gynecol Obstet. 2019;300(3):737–50. https://doi.org/10.1007/s00404-019-05210-z; https://www.risksafety.ru/jour/article/view/426
-
12Academic Journal
Authors: A. A. Abramov, А. А. Абрамов
Source: Epidemiology and Vaccinal Prevention; Том 23, № 2 (2024); 25-35 ; Эпидемиология и Вакцинопрофилактика; Том 23, № 2 (2024); 25-35 ; 2619-0494 ; 2073-3046
Subject Terms: мужское бесплодие, sexually transmitted infections, urogenital chlamydia, gonorrhea, complications, pelvic inflammatory diseases, female infertility, male infertility, инфекции, передающиеся половым путём, урогенитальный хламидиоз, гонорея, осложнения, воспалительные заболевания органов малого таза, женское бесплодие
File Description: application/pdf
Relation: https://www.epidemvac.ru/jour/article/view/1969/1021; Workowski KA, Bachmann LH, Chan PA, et al. Sexually Transmitted Infections Treatment Guidelines, 2021. MMWR Recomm Rep. 2021;70(4):1-187. doi:10.15585/mmwr.rr7004a1; Ross J, Guaschino S, Cusini M, Jensen J. 2017 European guideline for the management of pelvic inflammatory disease. Int J STD AIDS. 2018 Vol. 29, N2. P. 108-114.; Ross J, Cole M, Evans C, et al. United Kingdom national guideline for the management of pelvic inflammatory disease (2019 interim update) United Kingdom: British association for sexual health and HIV BASHH; 2019. URL: Guidelines for the Management of Pelvic Infection and Perihepatitis (bashh.org) (дата обращения 25.04.2024); Адамян, Л. В., Андреева, Е. Н., Артымук, Н. В. и др. Воспалительные болезни женских тазовых органов: Клинические рекомендации. Российское общество акушеров-гинекологов. 2021 C.46.; Скворцов, В. В., Скворцова, Е. М., Бангаров, Р. Ю., Матвеев, Н. Д. Современные представления о диагностике и лечении воспалительных заболеваний органов малого таза. Лечащий врач. 2022 №. 5-6. С.9-13.; Munro, K, Gharaibeh, A, Nagabushanam, S, Martin, C. Diagnosis and management of tubo-ovarian abscesses. The Obstetrician & Gynaecologist. 2018 N20. P. 11–9.; Mitchell CM, Anyalechi GE, Cohen CR, et al. Etiology and Diagnosis of Pelvic Inflammatory Disease: Looking Beyond Gonorrhea and Chlamydia. J Infect Dis. 2021 Vol. 224, N12 Suppl 2. P. S29-S35.; Mitchell C, Prabhu M. Pelvic inflammatory disease: current concepts in pathogenesis, diagnosis and treatment. Infect Dis Clin North Am. 2013 Vol. 27, N4. P. 793-809.; Heinonen PK, Miettinen A. Laparoscopic study on the microbiology and severity of acute pelvic inflammatory disease. Eur J Obstet Gynecol Reprod Biol. 1994 Vol. 57, N2. P. 85-89.; Short VL, Totten PA, Ness RB, et al. Clinical presentation of Mycoplasma genitalium Infection versus Neisseria gonorrhoeae infection among women with pelvic inflammatory disease. Clin Infect Dis. 2009 Vol. 48, N1 P. 41-47.; Moore MS, Golden MR, Scholes D, Kerani RP. Assessing Trends in Chlamydia Positivity and Gonorrhea Incidence and Their Associations With the Incidence of Pelvic Inflammatory Disease and Ectopic Pregnancy in Washington State, 1988-2010. Sex Transm Dis. 2016 Vol. 43, N1. P. 2-8.; Haggerty CL, Gottlieb SL, Taylor BD, et al. Risk of sequelae after Chlamydia trachomatis genital infection in women. J Infect Dis. 2010 Vol. 201, N.Suppl 2. P. S134–55.; Бебнева Т. Н., Дамирова К. Ф. К. Воспалительные заболевания органов малого таза. Гинекология. 2019 Т. 21, №. 5. С.39-44.; Герасимова, Н. А., Евстигнеева, Н. П., Малишевская, Н. П. и др. Заболеваемость гонококковой инфекцией, воспалительными заболеваниями органов малого таза и бесплодием в Российской Федерации и Уральском федеральном о. Лечащий врач. 2019 №. 4. С. 63-67.; Jennings LK, Krywko DM. Pelvic Inflammatory Disease. In: StatPearls. Treasure Island (FL): StatPearls Publishing; March 13, 2023.; Штах А. Ф., Баулина Н. В., Володина М. Ю. Динамика оказания стационарной медицинской помощи пациенткам с сальпингоофоритом в Пензенской области в 2015-2016 гг. Известия высших учебных заведений. Поволжский регион. Медицинские науки. 2018 №. 3 (47). С. 104-114.; Ross JD. Pelvic inflammatory disease. BMJ Clin Evid. 2013 Vol. 2013, N1606.; Westrom L. Effect of pelvic inflammatory disease on fertility. Venereology. Official Publication of the National Venereology Council of Australia. 1995 Vol.8, N4. P. 219-222.; Tsevat DG, Wiesenfeld HC, Parks C, Peipert JF. Sexually transmitted diseases and infertility. Am J Obstet Gynecol. 2017 Vol. 216, N1 P. 1-9.; Inhorn MC, Patrizio P. Infertility around the globe: new thinking on gender, reproductive technologies and global movements in the 21st century. Hum Reprod Update. 2015 Vol. 21, N4. P. 411-426.; Toomey KE, Collins JL, Lehnherr JR, et al. 2006 assisted reproductive technology success rates: national summary and fertility clinic reports. Atlanta: US Department of Health and Human Services. – 2013. URL: https://www.cdc.gov/art/Archived-PDF-Reports/2006ART.pdf; Инкарбек, Ж., Турсынбеков, Ж., Чакен, Е. и др. Роль урогенитальных инфекций в патогенезе развития мужского бесплодия. Вестник Казахского Национального медицинского университета. 2021 №.2. С.160-164.; https://www.epidemvac.ru/jour/article/view/1969
-
13Academic Journal
Authors: Наталия Ивановна Фролова
Source: Мать и дитя в Кузбассе, Vol 25, Iss 4, Pp 4-11 (2024)
Subject Terms: женское бесплодие, факторы риска, медицинская помощь, Pediatrics, RJ1-570, Gynecology and obstetrics, RG1-991
-
14
-
15
-
16
-
17Academic Journal
Authors: Cauş, C.G., Cauş, N.
Source: Buletin de Perinatologie 90 (1) 115-121
Subject Terms: infertile couple, male infertility, Female infertility, reproductive health, semen analysis-spermiogram, бесплодная пара, мужское бесплодие, женское бесплодие, репродуктивное здоровье, спермограмма, cuplu infertil, infertilitate masculină, infertilitate feminină, sănătate reproductivă, spermogramă
File Description: application/pdf
Relation: https://ibn.idsi.md/vizualizare_articol/137706; urn:issn:18105289
Availability: https://ibn.idsi.md/vizualizare_articol/137706
-
18Academic Journal
Authors: Cauș, Cătălin, Cauș, Natalia
Source: Buletin de Perinatologie 90 (1) 115-121
Subject Terms: мужское бесплодие, female infertility, бесплодная пара, sănătate reproductivă, cuplu infertil, male infertility, infertile couple, спермограмма, infertilitate masculină, Female infertility, reproductive health, semen analysis-spermiogram, spermogramă, репродуктивное здоровье, infertilitate feminină, женское бесплодие
File Description: application/pdf
Access URL: https://ibn.idsi.md/vizualizare_articol/137706
-
19Academic Journal
Authors: Khmil, S. V., Onyskiv, B. O., Lesniak, Yu. I., Davyd, L. V., Shliakhtych, M., Khmil, M. S., Yakymenko, H. V.
Source: Actual Problems of Pediatry, Obstetrics and Gynecology; No. 1 (2009) ; Актуальные вопросы педиатрии, акушерства и гинекологии; № 1 (2009) ; Актуальні питання педіатрії, акушерства та гінекології; № 1 (2009) ; 2415-301X ; 2411-4944 ; 10.11603/24116-4944.2009.1
Subject Terms: auxiliary reproductive technologies, women’s infertility, вспомогательные репродуктивные технологии, женское бесплодие, допоміжні репродуктивні технології, жіноче безпліддя
File Description: application/pdf
Relation: https://ojs.tdmu.edu.ua/index.php/act-pit-pediatr/article/view/9677/9333; https://repository.tdmu.edu.ua//handle/123456789/14845
-
20Academic Journal
Authors: Stepanovichus, O. M.
Source: Actual Problems of Pediatry, Obstetrics and Gynecology; No. 1 (2015) ; Актуальные вопросы педиатрии, акушерства и гинекологии; № 1 (2015) ; Актуальні питання педіатрії, акушерства та гінекології; № 1 (2015) ; 2415-301X ; 2411-4944 ; 10.11603/24116-4944.2015.1
Subject Terms: women's infertility, endometriosis, endosurgery, immunotherapy, женское бесплодие, эндометриоз, эндохирургия, иммунокоррекция, жіноче безпліддя, ендометріоз, ендохірургія, імунокорекція
File Description: application/pdf
Relation: https://ojs.tdmu.edu.ua/index.php/act-pit-pediatr/article/view/4715/4354; https://repository.tdmu.edu.ua//handle/123456789/14394